Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLECT: Everolimus in Liver Transplant
NCT02115113Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by Novartis. Started Mar 2014; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT02115113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115113.